Source: http://www.google.com/patents/US4861330?dq=No.+6,411,949&ei=AUR7T-LGJqSr0AHy2aSiBg
Timestamp: 2017-08-18 18:39:05
Document Index: 458541058

Matched Legal Cases: ['art 10', 'art 10', 'art 10', 'art 10', 'art 10', 'art, 25']

Patent US4861330 - Cardiac assist device and method - Google Patents
A device and method for assisting the pumping action of a failed heart. The device comprises an inelastic balloon, preferably conical in shape, connected to a catheter and pump. The balloon is percutaneously fed into a major blood vessel and then guided to a ventricle of the heart. When placed in the...http://www.google.com/patents/US4861330?utm_source=gb-gplus-sharePatent US4861330 - Cardiac assist device and method
Publication number US4861330 A
Application number US 07/024,986
Filing date Mar 12, 1987
Priority date Mar 12, 1987
Publication number 024986, 07024986, US 4861330 A, US 4861330A, US-A-4861330, US4861330 A, US4861330A
Inventors Gene Voss
Original Assignee Gene Voss
Patent Citations (18), Non-Patent Citations (2), Referenced by (186), Classifications (14), Legal Events (4)
Cardiac assist device and method
US 4861330 A
A device and method for assisting the pumping action of a failed heart. The device comprises an inelastic balloon, preferably conical in shape, connected to a catheter and pump. The balloon is percutaneously fed into a major blood vessel and then guided to a ventricle of the heart. When placed in the left ventricle, the balloon inflates during the isovolumetric contraction period before the aortic valve opens, and deflates after the aortic valve is closed but before the mitral valve has opened.
1. A method of assisting the pumping action of a heart, comprising the steps of:
inserting a balloon member into the femoral vein, said balloon member joined in fluid communication to a catheter member;
guiding said balloon member and said catheter member within said femoral vein toward said heart, into the inferior vena cava and the right atrium;
pushing said balloon member past the foramen ovale into the left atrium and past the mitral valve into the left ventricle of said heart; and
activating pump means connected to said catheter member whereby said balloon member is inflated during each contraction of said ventricle, and deflated shortly thereafter.
2. The method of claim 1 further comprising the step of placing said balloon member at the apical dimple of said left ventricle.
3. The method of claim 2 further comprising the step of securing said balloon member to the inner wall of said left ventricle by needle means attached to a tip of said balloon member.
4. The method of claim 3 further comprising the step of injecting a radiopaque dye into said ventricle before pushing said balloon member therein.
5. The method of claim 1 further comprising the step of securing said balloon member to the inner wall of said left ventricle by needle means attached to a tip of said balloon member.
6. The method of claim 1 further comprising the step of injecting a radiopaque dye into said ventricle before pushing said balloon member therein.
The present invention generally relates to devices for assisting the pumping action of the heart, and more particularly to an inflatable balloon to be placed within the heart itself.
Heart disease is the number one killer among persons over 30. The most common manifestation of this disease is heart attack, or myocardial infarction. A heart attack is usually caused by clogging of the coronary arteries, those vessels which supply oxygen and nutrients to the heart itself, often due to an excessive accumulation of lipid material (fat) within the arterial walls (coronary occlusion or thrombosis).
A milder heart attack may result in mere "heart failure," characterized by an inability of the heart to pump blood at the rate needed to maintain adequate blood flow throughout the body. In this scenario, blood flow through the coronary arteries is appreciably diminished, but not totally cut off. This results in decreased blood flow (ischemia) to localized portions of the muscular tissues of the heart, with possible necrosis. Inadequacy of the coronary blood supply may give rise to chest pains (angina pectoris), and lead to shortness of breath (dyspnea) and the accumulation of excessive fluids (edema) in the lungs, liver, and lower limbs. The heart reacts by pumping more forcibly and faster, but this typically causes the ventricles to grow larger and become flaccid. Although the volume of the ventricle is increased, the maximum pressure during the isovolumetric period is actually lowered.
In the past, devices have been invented to serve some of the needs of heart failure patients. One important medical tool devised to assist the failing heart is the intra-aortic, or intra-arterial, balloon (IAB). The IAB is usually inserted into the body via the femoral artery near the groin, and threaded up to the aorta. An early IAB is disclosed in U.S. Pat. No. 3,504,662, issued to R. Jones. That device provides a peristaltic pumping action. Another IAB, providing uni-directional pumping, is described in U.S. Pat. No. 3,692,018, issued to Goetz et al. The balloon may be placed in the ascending or descending portions of the aorta, and more than one balloon may be employed, as depicted in U.S. Pat. No. 4,527,549, issued to S. Gabbay.
Numerous other advances have occurred in IAB technology. U.S. Pat. No. 4,327,709, issued to Hanson et al. describes an apparatus for percutaneous introduction of an IAB through a dilator-sheath. Special features of the balloon have also been devised. For example, U.S. Pat. No. 4,346,698, also issued to Hansen et al., discloses an IAB which has a stylet therein for rotating the IAB so as to twist and thereby decrease the diameter of the IAB during insertion. Improvements on this idea are discussed in U.S. Pat. Nos. 4,402,307; 4,467,790; and 4,531,512.
Basically, the IAB is designed to inflate immediately upon the closing of the aortic valve, thereby expelling blood from the aorta into the connecting arteries. The synchronous timing of the balloon is controlled by electrical signals from the heart, i.e., by monitoring the EKG of the patient. The tip of the balloon may even be equipped with an electrode to provide this function, as shown in U.S. Pat. No. 4,552,127, issued to P. Schiff.
All of the above devices, however, suffer one critical disadvantage in that they take for granted that the heart will be able to force a sufficient amount of blood into the aorta in the first place. Where the efficiency of cardiac output is severely affected by myocardial stretching, systemic blood pressure can drop from 130/80 to as low as 50/30. In such cases, an intraaortic balloon is, at best, a band-aid remedy.
It would therefore be desirable and advantageous to devise an intraventricular balloon to assist the pumping action of the heart. No such device yet exists, although an article by Donald et al., published in the Journal of Thoracic and Cardiovascular Surgery, vol. 63, no. 5 (May 1972), discusses open heart experiments employing a cardiac balloon pump on a dog.
Accordingly, the primary object of the present invention is to provide a device for assisting the pumping action of the human heart.
Another object of the invention is to provide such a device which will actually be placed within the heart.
Still another object of the invention is to provide a method of employing such a device.
Yet another object of the invention is to provide a method of percutaneous retrograde introduction of the device into the heart.
The foregoing objects are achieved in a cardiac assist device comprising an intra-ventricular balloon and support system. The intra-ventricular balloon may be introduced into either the left or right ventricles via the femoral artery or vein, respectively, or may pass through the atria to the left ventricle. Additional intra-aortic balloons may be used in conjunction with the intraventricular balloon.
FIG. 1 is a schematic diagram of the heart showing cardiac blood flow.
FIG. 2 is a cross-sectional view of the intra-ventricular balloon and catheter, also showing the supporting pump system.
FIGS. 3A-3D show various embodiments of the balloon itself.
FIG. 4A is cross-sectional representation of the left ventricle of the heart with the deflated balloon therein; FIG. 4B shows the balloon inflated.
FIG. 5 is similar to FIGS. 4A and 4B, but it depicts the balloon located within the right ventricle.
FIG. 6A is also similar to FIG. 4B, but it additionally depicts an intra-aortic balloon working in conjunction with the ventricular balloon; FIG. 6B shows a cross-section taken along lines 6B--6B of FIG. 6A; FIG. 6C shows an analogous cross-section of an alternative embodiment.
FIG. 7 shows an alternative method of placement of the balloon within the left ventricle, the catheter passing through the left and right atria.
With reference now to the FIGS., and in particular with reference to FIG. 1, there is depicted a schematic diagram of the human heart 10. Blood flow is detailed by directional arrows. It should be understood that all of the figures only schematically depict the heart, as these diagrams are not physically accurate.
Before discussing the structure and operation of the invention, a brief explanation of cardiac hemodynamics is necessary. Cardiac blood flow may be said to begin at the juncture of the superior and inferior venae cavae, 12 and 14 respectively, where all oxygen-depleted blood in the body is forced into the right atrium 16. The natural pumping action of the heart draws the blood through the tricuspid (atrioventricular) valve 18 into the right ventricle 20. Right ventricle 20 then drives the blood to the lungs via pulmonary arteries 22. Oxygenated blood returns from the lungs to the heart by way of pulmonary veins 24 which lead into the left atrium 26, passing then through mitral (bicuspid) valve 28 into the left ventricle 39. Contraction of left ventricle 30 forces the blood into aorta 32 which then distributes the blood throughout the body.
The ventricle walls are generally thicker than the walls of the atria, necessary for pumping the blood against the pressure in the arteries. The left ventricular wall is even thicker than the right ventricular wall, the bulk of the wall comprising the myocardium, being thick bands of muscular tissue. The left ventricle is the most critical component of the heart as it provides the maximum pressure during the systolic phase of the cardiac cycle to power the entire circulatory system. Because of its thicker nature, and its increased workload, it is usually the myocardial layer of this ventricle that suffers necrosis or ischemia during a heart attack. For this reason, it is anticipated that the intra-cardial balloon will most often be placed within a suffering left ventricle.
The balloon itself as well as the supporting pump system is generally represented in FIG. 2. Balloon 40 is located at the distal end of a catheter 42 which in turn is connected to pump 44. A wire or stylet 46 runs from the tip 48 of balloon 40 through aperture 38 and catheter 42 and diverges therefrom into branch tube 50. Tip 48 of balloon 40 may be equipped with a needle 52 for securing the balloon within the ventricle, as discussed below. Stylet 46 terminates at knob 54 which may be used to twist stylet 46 as described in U.S. Pat. No. 4,346,698, which is hereby incorporated for all purposes. Twisting stylet 46 is desirable to minimize the effective diameter of the deflated balloon 40 as it is inserted into the body. Stylet 46 also provides structural integrity for balloon 40.
Balloon 40 is preferably conical shaped to correspond to the shape of the inner wall (endocardium) of the ventricle. It should be made of an inelastic, nonthrombogenic material, such as polyvinyl chloride. The volume of balloon 40 should be between 10 and 80 milliliters, but is dependent on many factors, such as the impedance of flow out of the aorta. A higher impedance would require a higher balloon volume. The balloon volume is also dependent on the tone of the ventricle. Good myocardial tone would require a small balloon, say 15 ml., but if the ventricle were highly distended (or highly distendable) a larger balloon, e.g., 60 ml., might be necessary. Similarly, an aneurismal dilation within the ventricle would require a larger balloon. As a general rule, the balloon size should never be less than twenty-five percent (25%) of the left ventricular end diastolic volume.
Balloon 40 may come in many different shapes, as can be seen by reference to FIGS. 3A-3D. As previously mentioned, balloon 40 is preferably conical, as shown in FIG. 3A, having a length a between 3 and 6 centimeters, and a width b at the base between 2.5 and 5 centimeters, depending on the desired volume. For example, a balloon having a volume of 50 ml. would have an approximate length of 5 cm and a width of 4 cm. Other shapes include a slender balloon (FIG. 3B), spherical (FIG. 3C), or "bell pepper" shaped (FIG. 3D) where the tip 48 is somewhat recessed.
Balloon pump 44 must be capable of inflating and deflating balloon 40 with a time period of about 100 milliseconds. This is critical as the balloon 40 should be completely inflated during the isovolumetric period of ventricular contraction (about 45 ms.), and deflated while aortic valve 32 is still open. The balloon 40 should be deflated while aortic valve 32 is still open in order to avoid obstruction of blood outflow. Of course, the inflation/deflation cycle is dependent upon the specific characteristics of each individual heart. The inflation/deflation period may actually be anywhere from 50 to 200 milliseconds.
Pump 44 must provide pressures of 150 millimeters of mercury or more. Timing of the inflation-deflation cycle may be accomplished by coordination with the EKG of the heart (i.e., beginning inflation using the Q-R-S event of the PQRST signal). An electrode may actually be placed on tip 48 of balloon 40 for this purpose, as disclosed in U.S. Pat. No. 4,552,127. For a more thorough discussion of balloon pumps and their activation, see U.S. Pat. No. 3,266,487, which is hereby incorporated for all purposes. In practice, a balloon pump produced by the Datascope Corp. of Oakland, N.J., Model No. 9000 is satisfactory for these purposes. Although any relatively inert gas may be used to pump balloon 40, helium is preferred as its lower viscosity is more suited for the short inflation-deflation cycles involved here.
Catheter 42 has an outer diameter between 4 and 12 french, preferably about 8 french. As it is typically inserted near the groin, it should be from 50 to 80 centimeters long. Excess length is undesirable as increases pump resistance. The catheter 42 may be made of polyurethane, or coated with some nonthrombogenic substance such as heparin.
The technique for initial insertion of the ventricular balloon into the body is generally the same as previously known. As discussed in U.S. Pat. No. 4,327,709, which is hereby incorporated for all purposes, a puncture is made in the patient's skin, subcutaneous tissue, and major blood vessel, usually the femoral artery. A cannula may be inserted into the puncture to facilitate guiding balloon 40 and catheter 42 into the artery. The balloon 40 is then threaded upwards within the artery toward heart 10. This procedure is known as percutaneous retrograde introduction.
The skilled surgeon will know when the balloon 40 is nearing heart 10. At this time, radiopaque dye may be injected into the left ventricle in order to assist the passage of balloon 40 through aortic valve 32. The surgeon may anticipate the opening of aortic valve 32 by the EKG of the patient, and thereby discern when to apply longitudinal pressure to the exposed portion of catheter 42. Of course, balloon 40 is kept deflated during this portion of the procedure.
After balloon 40 has passed through aortic valve 32, the tip 48 of balloon 40 is preferably placed at the apical dimple 31 of left ventricle 30, as depicted in FIG. 4A. Placement of balloon 40 near apical dimple 31 allows balloon 40 to roll up along the ventricular wall, thus minimizing damage to the endocardium and avoiding entrapment of blood between balloon 40 and the ventricular wall. Balloon 40 may be securely fixed to the apical dimple by means of a needle 52 placed at the tip 48 of balloon 40. Needle 52 may be in the shape of a hook, so as to be essentially permanently lodged within the endocardium, or alternatively, it may straight. In the latter case, it is envisioned that the needle 52 may actually pierce the wall of heart 10, including the pericardium, and that it may be secured external to heart 10 in thoracic surgery. In any event, needle 52 is not essential to the operation of balloon 40 as sufficient longitudinal force along catheter 42 compels the tip 48 of balloon 40 to the apical dimple 31. With balloon 40 in place, pump 44 may be activated. The inflated balloon is depicted in FIG. 4B.
The normal size of the left ventricle 30 of an adult human heart varies from about 100 ml. to 175 ml. The amount of blood exiting the left ventricle of a healthy person during systole is about 60% of this volume. Taking as an example an individual whose ventricular volume is about 125 ml., we might say that about 75 ml. of blood flows into the aorta in one cardiac cycle. In a failed heart, 25% or less of the ventricular volume is ejected, e.g., 30 ml. It is anticipated that use of intra-ventricular balloon 40 will increase the cardiac output in such a case by at least 50%, and probably 100% or more. The total amount of blood ejected will at least equal the volume of the balloon, say 50 ml. for the above facts. It is important to note, however, that the volumetric displacement of balloon 40 is not as meaningful as the increased ventricular pressure caused by the inflation thereof during the isovolumetric contraction period. It is this increased pressure that significantly contributes to cardiac output.
In more serious cases, the ventricle may become distended, resulting in a volume of up to 250 ml., but in such a case, the ventrical loses much of its pumping ability and as little as 5% of this volume is ejected. Intra-ventricular balloon 40 is most effective in these cases; a 75 ml. balloon could raise cardiac output from 15 ml. to 80 ml. or more. Although regurgitation through aortic valve 32 is likely due to the presence of catheter 32 therein, it is anticipated that no more than 10% of the gross blood flow will be so regurgitated. Thus intra-ventricular balloon 40 has clear advantages over prior art devices. Furthermore, the increased systolic pressure contributes to enhanced blood flow in coronary artery 36. This can actually revitalize the heart in cases where the myocardium suffers from localized ischemia rather than necrosis.
Use if intra-ventricular balloon 40 is not limited to the left ventricle, but may also be used in right ventricle 20. Most cases of heart failure are due to myocardial infarction of the left ventricle, but in cases where the right ventricle is damaged or becomes distended, placement of balloon 40 within right ventricle 20 will augment blood flow, especially pulmonary circulation. As depicted in FIG. 5, balloon 40 and catheter 42 may be inserted in the femoral vein and maneuvered to inferior vena cava 14. In a manner similar to that described above, balloon 40 is then pushed into right atrium 16, through tricuspid valve 18, and finally into right ventricle 20. Balloons could even be placed in both the left and right ventricles.
Intra-ventricular balloon 40 may be used alone or in conjunction with other prior art intra-aortic balloon. FIG. 6A shows such apparatus. Here, intraventricular balloon 40 has been placed in left ventricle 30, and a second aortic balloon 56 is positioned in the descending aorta. An intraventricular balloon 40 and intra-aortic balloon 56 must be inflated asynchronously, separate airways must be provided to pump 44. FIG. 6B depicts one way in which this may be done. In this embodiment, an outer catheter 43 surrounds catheter 42. Outer catheter 43 terminates where intra-aortic balloon 56 begins, while catheter 42 continues within balloon 56 and leads to intra-ventricular balloon 40 within the heart. The preferred design for such an arrangement, however, is shown in FIG. 6C where catheter 42 is divided into two airways by partition 41. Stylet 46 may run inside partition 41, and one airway simply opens and terminates at intra-aortic balloon 56.
Another method of using intra-ventricular balloon 40 is shown in FIG. 7. In some instances, the femoral artery may be undesirable for percutaneous retrograde insertion, or the aortic valve 32 may have been damaged to the extent that placement of a catheter therein would be fatal. In such a case, the left ventricle may actually be reached via the right atrium. There is a thin layer in the septum 58 dividing the atria known as the foramen ovale. Foramen ovale 60 begins as an aperture in the fetal heart until the middle period of fetal life. It then grows a fold from the posterior wall which acts as a sort of valve, allowing blood to pass only from the right to the left atrium. The balloon and catheter are again threaded through the femoral vein to inferior vena cava 14, into right atrium 16, and through foramen ovale 60 into left atrium 26. From there it passes through mitral valve 28 into left ventricle 30 where it is secured as discussed above. Obviously this technique is less desirable as it has more complications than introduction via the femoral artery.
It is believed that the primary use of this technique will be temporary in nature, for those patients whose hearts have failed to the point that they must be kept on some sort of external life support system while awaiting a heart transplant. It is conceivable, however, that once implanted, the cardiac assist device as disclosed could be made portable and somewhat permanent.
US3087486 * Mar 5, 1959 Apr 30, 1963 Cenco Instr Corp Cardiac electrode means
US3266487 * Jun 4, 1963 Aug 16, 1966 Sundstrand Corp Heart pump augmentation system and apparatus
US3504662 * May 16, 1967 Apr 7, 1970 Avco Corp Intra-arterial blood pump
US3692018 * Feb 11, 1970 Sep 19, 1972 Lionel J Goetz Cardiac assistance device
US4327709 * Oct 18, 1979 May 4, 1982 Datascope Corp. Apparatus and method for the percutaneous introduction of intra-aortic balloons into the human body
US4346598 * Jun 19, 1980 Aug 31, 1982 General Motors Corporation Cam actuated fuel modulating engine governor
US4402307 * Oct 31, 1980 Sep 6, 1983 Datascope Corp. Balloon catheter with rotatable energy storing support member
US4467790 * Jun 6, 1983 Aug 28, 1984 Peter Schiff Percutaneous balloon
US4475560 * Apr 29, 1982 Oct 9, 1984 Cordis Corporation Temporary pacing lead assembly
US4515587 * Feb 14, 1983 May 7, 1985 Smec, Inc. IAB having apparatus for assuring proper balloon inflation and deflation
US4531512 * Jan 4, 1984 Jul 30, 1985 Datascope Corporation Wrapping system for intra-aortic balloon utilizing a wrapping envelope
US4552127 * Apr 1, 1983 Nov 12, 1985 Peter Schiff Percutaneous intra-aortic balloon having an EKG electrode and a twisting stylet for coupling the EKG electrode to monitoring and/or pacing instrumentation external to the body
US4595012 * Jan 13, 1984 Jun 17, 1986 American Hospital Supply Corporation Lumen mounted electrodes for pacing and intra-cardiac ECG sensing
US4602645 * Dec 16, 1982 Jul 29, 1986 C. R. Bard, Inc. Atrio-ventricular pacing catheter
US4685446 * Feb 21, 1984 Aug 11, 1987 Choy Daniel S J Method for using a ventricular assist device
US4771765 * Dec 16, 1985 Sep 20, 1988 Choy Daniel S J Heart assist device and method of use
1 The Journal of Thoracic and Cardiovascular Surgery, "Sustained Circulation by a Left Ventricular Balloon Pump after Severe Myocardial Damage in Dogs", by David E. Donald, Ph.D., Alfred A. Bove, M.D. and Dwight C. McGoon, M.D., vol. 63, No. 5, pp. 681-695, May 1972.
2 * The Journal of Thoracic and Cardiovascular Surgery, Sustained Circulation by a Left Ventricular Balloon Pump after Severe Myocardial Damage in Dogs , by David E. Donald, Ph.D., Alfred A. Bove, M.D. and Dwight C. McGoon, M.D., vol. 63, No. 5, pp. 681 695, May 1972.
US4969865 * Jan 9, 1989 Nov 13, 1990 American Biomed, Inc. Helifoil pump
US5045051 * Mar 14, 1989 Sep 3, 1991 Abiomed, Inc. Leak detector
US5112292 * Oct 25, 1990 May 12, 1992 American Biomed, Inc. Helifoil pump
US5176619 * May 5, 1989 Jan 5, 1993 Jacob Segalowitz Heart-assist balloon pump with segmented ventricular balloon
US5308319 * Dec 30, 1992 May 3, 1994 Sumitmo Bakelite Company Limited Cardio assist system and insertion device therefor
US5383854 * Aug 19, 1992 Jan 24, 1995 University Of Pittsburgh Of The Commonwealth System Of Higher Education Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method
US5509428 * May 31, 1994 Apr 23, 1996 Dunlop; Richard W. Method and apparatus for the creation of tricuspid regurgitation
US5676670 * Jun 14, 1996 Oct 14, 1997 Beth Israel Deaconess Medical Center Catheter apparatus and method for creating a vascular bypass in-vivo
US5820593 * Apr 25, 1996 Oct 13, 1998 University Of Pittsburg Of The Commonwealth System Of Higher Education Portable and modular cardiopulmonar bypass apparatus and associated aortic balloon catheter and associated method
US5879316 * Apr 10, 1997 Mar 9, 1999 University Of Pittsburgh Of The Commonwealth System Of Higher Education Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method
US5906588 * Aug 11, 1997 May 25, 1999 Cardeon Corporation Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon and associated method
US5928132 * Mar 31, 1998 Jul 27, 1999 Datascope Investment Corp. Closed chest intra-aortic balloon based ventricular assist device
US6086527 * Apr 2, 1998 Jul 11, 2000 Scimed Life Systems, Inc. System for treating congestive heart failure
US6110100 * Apr 22, 1998 Aug 29, 2000 Scimed Life Systems, Inc. System for stress relieving the heart muscle and for controlling heart function
US6149578 * Feb 4, 1999 Nov 21, 2000 My-Tech, Inc. Piston-action intra-aortic coronary assist device
US6165162 * Sep 14, 1998 Dec 26, 2000 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of using aortic balloon catheter
US6228018 * Feb 5, 1999 May 8, 2001 My-Tech, Inc. Removable left ventricular assist device with an aortic support apparatus
US6248121 Jul 23, 1998 Jun 19, 2001 Cardio Medical Solutions, Inc. Blood vessel occlusion device
US6280377 Jul 10, 2000 Aug 28, 2001 Scimed Life Systems, Inc. System for treating congestive heart failure
US6350248 Apr 13, 2000 Feb 26, 2002 Heartstent Corporation Expandable myocardial implant
US6361519 Apr 13, 2000 Mar 26, 2002 Heartstent Corporation Mesh tip myocardial implant
US6406422 Mar 2, 2000 Jun 18, 2002 Levram Medical Devices, Ltd. Ventricular-assist method and apparatus
US6408203 Feb 27, 2001 Jun 18, 2002 Robert A. Mackin Apparatus and method for contemporaneous treatment and fluoroscopic mapping of body tissue
US6701932 Jan 9, 2002 Mar 9, 2004 Percardia, Inc. Method and apparatus for revascularizing a coronary vessel with an implant having a tapered myocardial leg
US6749598 Jan 11, 1999 Jun 15, 2004 Flowmedica, Inc. Apparatus and methods for treating congestive heart disease
US6932792 * Jul 17, 2000 Aug 23, 2005 Frederick G. St. Goar Antegrade cardioplegia catheter and method
US6994700 Mar 18, 2005 Feb 7, 2006 Flowmedica, Inc. Apparatus and method for inserting an intra-aorta catheter through a delivery sheath
US7063679 Sep 20, 2002 Jun 20, 2006 Flowmedica, Inc. Intra-aortic renal delivery catheter
US7104981 Oct 25, 2005 Sep 12, 2006 Flowmedica, Inc. Apparatus and method for inserting an intra-aorta catheter through a delivery sheath
US7122019 Nov 28, 2000 Oct 17, 2006 Flowmedica Inc. Intra-aortic renal drug delivery catheter
US7241273 Aug 6, 2003 Jul 10, 2007 Flowmedica, Inc. Intra-aortic renal delivery catheter
US7320665 * Jul 14, 2006 Jan 22, 2008 Venkataramana Vijay Cardiac Ventricular Geometry Restoration Device and Treatment for Heart Failure
US7329236 Sep 7, 2005 Feb 12, 2008 Flowmedica, Inc. Intra-aortic renal drug delivery catheter
US7335192 May 13, 2003 Feb 26, 2008 Flowmedica, Inc. Apparatus and methods for treating congestive heart disease
US7341570 Jul 3, 2003 Mar 11, 2008 Flowmedica, Inc. Apparatus and methods for treating congestive heart disease
US7347810 Oct 1, 2004 Mar 25, 2008 Stamos Thomas A Device for draining the coronary sinus
US7364566 Mar 18, 2005 Apr 29, 2008 Flowmedica, Inc. Method and apparatus for intra-aortic substance delivery to a branch vessel
US7481803 Apr 23, 2003 Jan 27, 2009 Flowmedica, Inc. Intra-aortic renal drug delivery catheter
US7563247 Aug 6, 2003 Jul 21, 2009 Angiodynamics, Inc. Intra-aortic renal delivery catheter
US7585836 May 13, 2005 Sep 8, 2009 Goodson Iv Harry Burt Bi-lateral local renal delivery for treating congestive heart failure and for BNP therapy
US7766961 Dec 5, 2005 Aug 3, 2010 Angio Dynamics, Inc. Systems and methods for performing bi-lateral interventions or diagnosis in branched body lumens
US7771401 Jun 5, 2007 Aug 10, 2010 Angiodynamics, Inc. Selective renal cannulation and infusion systems and methods
US7780628 May 1, 2000 Aug 24, 2010 Angiodynamics, Inc. Apparatus and methods for treating congestive heart disease
US7798815 * Apr 3, 2003 Sep 21, 2010 University Of The West Indies Computer-controlled tissue-based simulator for training in cardiac surgical techniques
US7914503 Mar 16, 2005 Mar 29, 2011 Angio Dynamics Method and apparatus for selective material delivery via an intra-renal catheter
US7993325 Sep 29, 2005 Aug 9, 2011 Angio Dynamics, Inc. Renal infusion systems and methods
US8007428 Jan 22, 2008 Aug 30, 2011 Venkataramana Vijay Cardiac ventricular geometry restoration device and treatment for heart failure
US8012121 Jun 26, 2007 Sep 6, 2011 Angiodynamics, Inc. Method and apparatus for selective material delivery via an intra-renal catheter
US8221303 * Apr 23, 2007 Jul 17, 2012 Yoel Ovil Intra-ventricular cardiac assist device and related method of use
US8518011 Aug 28, 2009 Aug 27, 2013 Angiodynamics, Inc. Sheath for use in peripheral interventions
US8540618 Feb 2, 2004 Sep 24, 2013 L-Vad Technology, Inc. Stable aortic blood pump implant
US8579788 Mar 8, 2010 Nov 12, 2013 Wilmo Orejola Auto-regulated R-wave synchronized intraventricular balloon pump heart assist device
US8585678 Mar 7, 2008 Nov 19, 2013 Angiodynamics, Inc. Method and apparatus for intra-aortic substance delivery to a branch vessel
US9433715 Aug 21, 2013 Sep 6, 2016 L-Vad Technology, Inc. Stable aortic blood pump implant
US9623163 Feb 11, 2016 Apr 18, 2017 Michael Fischi Left ventricle heart-assist device
US9694122 * May 13, 2014 Jul 4, 2017 L-Vad Technology, Inc. Rigid body aortic blood pump implant
US20030050659 * Jul 31, 2002 Mar 13, 2003 Chase Medical, Lp Ventricular restoration shaping apparatus
US20040033477 * Apr 3, 2003 Feb 19, 2004 Ramphal Paul S. Computer-controlled tissue-based simulator for training in cardiac surgical techniques
US20040059276 * Sep 20, 2002 Mar 25, 2004 Flomedica, Inc. Intra-aortic renal delivery catheter
US20040064089 * Apr 23, 2003 Apr 1, 2004 Kesten Randy J. Intra-aortic renal drug delivery catheter
US20040064091 * May 13, 2003 Apr 1, 2004 Gad Keren Apparatus and methods for treating congestive heart disease
US20040097900 * Jul 3, 2003 May 20, 2004 Gad Keren Apparatus and methods for treating congestive heart disease
US20050057180 * Sep 17, 2003 Mar 17, 2005 Changaris David G. Method and circuit for repetitively firing a flash lamp or the like
US20050203564 * Sep 5, 2002 Sep 15, 2005 Nobles Anthony A. Blood vessel occlusion device
US20060064059 * Sep 21, 2005 Mar 23, 2006 Mark Gelfand Treatment of infarct expansion by partially occluding vena cava
US20060074378 * Oct 1, 2004 Apr 6, 2006 Stamos Thomas S Device for draining the coronary sinus
US20060137697 * Oct 6, 2005 Jun 29, 2006 Chase Medical, L.P. Ventricular restoration shaping apparatus and method of use
US20060189960 * Sep 7, 2005 Aug 24, 2006 Flowmedica, Inc. Intra-aortic renal drug delivery catheter
US20060293739 * Jul 14, 2006 Dec 28, 2006 Venkataramana Vijay Cardiac Ventricular Geometry Restoration Device and Treatment for Heart Failure
US20070287880 * Apr 23, 2007 Dec 13, 2007 Yoel Ovil Intra-ventricular cardiac assist device and related method of use
US20090131785 * Nov 14, 2008 May 21, 2009 University Of Florida Research Foundation, Inc. Variable occlusional balloon catheter assembly
US20110218382 * Mar 8, 2010 Sep 8, 2011 Wilmo Orejola Auto-regulated R-Wave Synchronized Intraventricular Balloon Pump Heart Assist Device
US20110230821 * Mar 7, 2011 Sep 22, 2011 Uros Babic Manual assembly for cardio-circulatory resuscitation
CN104174078A * Sep 15, 2014 Dec 3, 2014 湖南埃普特医疗器械有限公司 Left ventricle auxiliary device
WO1990013322A1 * May 7, 1990 Nov 15, 1990 Jacob Segalowitz Heart-assist balloon pump
WO2008005747A2 * Jun 26, 2007 Jan 10, 2008 Moreschi Rafael M Trans-septal heart assist devices and methods of use
WO2008005747A3 * Jun 26, 2007 Dec 4, 2008 Rafael M Moreschi Trans-septal heart assist devices and methods of use
WO2008010792A1 * Jul 14, 2006 Jan 24, 2008 Venkataramana Vijay Cardiac ventricular geometry restoration device and treatment for heart failure
U.S. Classification 600/18, 606/194, 604/914
International Classification A61M1/12, A61M1/10
Cooperative Classification A61M1/1008, A61M1/1072, A61M1/122, A61M1/125, A61M1/12, A61M1/1074, A61M2205/32, A61M1/106